Cancer Biomarkers Funding Opportunities

Title Announcement # Expiration Datesort descending
U.S.-China Program for Biomedical Collaborative Research RFA-CA-19-009 (R01 Clinical Trial Optional)
[field_announcement_2]
02/22/2019
Mechanisms of Disparities in Chronic Liver Diseases and Cancer PAR-17-150 (R21)
[field_announcement_2]
04/05/2019
Program to Assess the Rigor and Reproducibility of Exosome-Derived Analytes for Cancer Detection PAR-16-276 (R01)
[field_announcement_2]
06/14/2019
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research RFA-CA-19-020 (R33 Clinical Trials Not Allowed)
[field_announcement_2]
09/28/2019
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research RFA-CA-19-019 (R21 Clinical Trials Not Allowed)
[field_announcement_2]
09/28/2019
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research RFA-CA-19-021 (R21 Clinical Trials Not Allowed)
[field_announcement_2]
09/28/2019
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research RFA-CA-19-022 (R33 Clinical Trials Not Allowed)
[field_announcement_2]
09/28/2019
Academic-Industrial Partnerships to Translate and Validate in vivo Cancer Imaging Systems PAR-18-009 (R01 Clinical Trial Optional)
[field_announcement_2]
11/06/2019
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 - Clinical Trials Not Allowed PAR-18-310
[field_announcement_2]
10/09/2020
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 - Clinical Trials Not Allowed) PAR-18-317
[field_announcement_2]
10/09/2020
Oncology Co-Clinical Imaging Research Resources to Encourage Consensus on Quantitative Imaging Methods and Precision Medicine PAR-18-841 (U24 - Clinical Trial Optional)
[field_announcement_2]
06/15/2021
Advancing Translational and Clinical Probiotic/Prebiotic and Human Microbiome Research PA-18-902 (R01 Clinical Trial Optional)
[field_announcement_2]
09/08/2021
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research PAR-19-113 (R01 Clinical Trial Optional)
[field_announcement_2]
01/08/2022